The genetics of fibromyalgia syndrome

Pharmacogenomics

Volumn 8, Issue 1, 2007, Pages 67-74

  Buskila, Dan ^a   Sarzi Puttini, Piercarlo ^b   Ablin, Jacob N ^c  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b UNIVERSITY OF MILAN   (Italy)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Familial aggregation; Fibromyalgia; Gene polymorphisms; Genetics

Indexed keywords

ANTIDEPRESSANT AGENT; CATECHOLAMINE; DOPAMINE; NEUROLEPTIC AGENT; PRAMIPEXOLE; SEROTONIN;

CATECHOLAMINERGIC SYSTEM; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DNA POLYMORPHISM; DOPAMINERGIC SYSTEM; FAMILIAL DISEASE; FAMILY STUDY; FIBROMYALGIA; FUNCTIONAL DISEASE; GENE LOCATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; IRRITABLE COLON; PATHOGENESIS; PHENOTYPE; PROMOTER REGION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM;

ANIMALS; FATIGUE SYNDROME, CHRONIC; FIBROMYALGIA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PAIN; POLYMORPHISM, GENETIC;

EID: 33846537316     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.8.1.67     Document Type: Review

References (37)

1. Wolfe F, Smythe H, Yunus MB et al.: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum. 33 (2), 160-172 (1990).
2. Mease P: Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J. Rheumatol. Suppl. 75, 6-21 (2005).
3. Buskila D, Neumann L, Press J: Genetic factors in neuromuscular pain. CNS Spectrums 10(4), 281-284 (2005).
4. Buskila D, Neumann L: Genetics of fibromyalgia. Curr. Pain Headache Res. 9(5), 313-315 (2005).
5. Clauw DJ. Crofford L: Chronic widespread pain and fibromyalgia: What we know, and what we need to know. Best Pract. Res. Clin. Rheumatol. 17(4), 685-701 (2003).
6. Buskila D, Neumann L, Hazanov I, Carmi R: Familial aggregation in the fibromyalgia syndrome. Semin. Arthritis Rheum. 26(3), 605-611 (1996).
7. Buskila D, Neumann L: Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM. J. Rheumatol. 24(5), 941-944 (1997).
8. Arnold LM, Hudson J, Hess EV et al.: Family study of fibromyalgia. Arthritis Rheum. 50(3), 944-952 (2004).
9. Kato K, Sullivan P, Evengard B, Pedersen NL: Importance of genetic influences on chronic widespread pain. Arthritis Rheum. 54 (5), 1682-1686 (2006).
10. Aaron LA, Buchwald D: Fibromyalgia and other unexplained clinical conditions. Curr. Rheumatol. Rep. 3(2), 116-122 (2001).
11. Hudson JI, Mangweth B, Pope HG Jr et al.: Family study of affective spectrum disorder. Arch. Gen. Psychiatry 60(2), 170-177 (2003).
12. Hudson JI, Arnold L, Keck PE Jr, Auchenbach MB, Pope HG Jr: Family study of fibromyalgia and affective spectrum disorder. Biol. Psychiatry 56(11), 884-891 (2004).
13. Walsh CM, Zainal N, Middleton SJ, Paykel ES: A family history study of chronic fatigue syndrome. Psychiatr. Genet 11 (3), 123-128 (2001).
14. Kalantar JS, Locke Gr, Zinsmetster AR, Beighley CM, Talley NJ: Familial aggregation of Irritable bowel syndrome: a prospective study. Gut 52 (12), 1703-1707 (2003).
15. Bondy B, Spaeth M, Offenbaecher M et al.: The T102C polymorphism of the 5-HT2A receptor gene in fibromyalgia. Neurobiol. Dis. 6(5), 433-439 (1999).
16. Chen K, Yang W, Grimsby J, Shih JC: The human 5-HT2 receptor is encoded by a multiple intron-exon gene. Brain Res. Molec. Brain Res. 14(1-2), 20-26 (1992).
17. Ramamoorthy S. Bauman A, Moore KR et al.: Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc. Natl Acad. Sci. USA 90(6), 2542-2546 (1993).
18. Offenbaecher M, Bondy B, de Jonge S et al.: Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum. 42(11). 2482-2488 (1999).
19. Cohen H, Buskila D, Neumann L, Ebstein RP: Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5-HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Arthritis Rheum. 46(3), 845-847 (2002).
20. Gursoy S: Absence of assocation of the serotonin transporter gene polymorphism with the mentally healthy subset of fibromyalgia patients. Clin. Rheumatol. 21(3), 194-197 (2002).
21. Shifman S, Bronstein M, Sternfeld M et al.: A highly significant association between a COMT haplotype and schizophrenia. Am. J. Hum. Genet. 71(6), 1296-1302 (2002).
22. Zubieta JK, Heitzeg M, Smith YR et al.: COMTVal158Met genotype affects μ-opioid neurotransmitter responses to a pain stressor. Science 299(5610), 1240-1243 (2003).
23. Gursoy S, Erdal E, Herken H, Madenci E. Alasehirli B, Erdal N. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol. Int. 23(3), 104-107 (2003).
24. Diatchenko L, Slade G, Nackley AG et al.: Genetic basis for Individual variations in pain perception and the development of a chronic pain condition. Hum. Mol. Genet. 14(1), 135-143 (2005).
25. Van Tol HH, Wu C, Guan HC et al.: Multiple dopamine D4 receptor variants in the human population. Nature 358(6382). 149-152 (1992).
26. Ebstein RP, Novick O, Umansky R et al.: Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nat. Genet. 12(1), 78-80 (1996).
27. Buskila D, Cohen H, Neumann L, Ebstein RP: An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits. Mol. Psychiatry 9(8), 730-731 (2004).
28. Narita M, Nishigami N, Narita N et al. Association between serotonin transporter gene polymorphism and chronic fatigue syndrome. Biochem. Biophys. Res. Commun. 14(311), 264-266 (2003).
29. Heils A, Teufel A, Petri S et al.: Allelic variation of human serotonin transporter gene expression. J. Neurochem 66(6), 2621-2624 (1996).
30. Yeo A, Boyd P. Lumsden S et al.: Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut 53(10), 1452-1458 (2004).
31. Pata C, Erdal E, Yazc K, Camdeviren H, Ozkaya M, Ulu O: Association of the - 1438 G/A and 102 T/C polymorphism of the 5-HT2A receptor gene with irritable bowel syndrome 5-HT2A gene polymorphism in irritable bowel syndrome. J. Clin. Gastroenterol. 38(7), 561-566 (2004).
32. 2 adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut 53(6), 829-837 (2004).
33. Mutlu N, Erdal M, Herken H, Oz G, Bayazit YA: T102C polymorphism of the 5-HT2A receptor gene may be associated with temporomandibular dysfunction. Oral Dis. 10(6), 349-352 (2004).
34. Juhasz G, Zesombok T, Laszik A et al.: Association analysis of 5-HTTLPR variants, 5-HT2A receptor gene 102T/C polymorphism and migraine. J Neurogenet. 17(2-3), 231-240 (2003).
35. Borroni B, Brambilla C, Liberini P et al.: Functional serotonin 5-HTTLPR polymorphism is a risk factor for migraine with aura. J. Headache Pain 6(4), 182-184 (2005).
36. Lee HJ, Lee M, Kang RH et al: Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder. Depress. Anxiet. 21(3). 135-139 (2005).
37. Frank B, Niesler B, Bondy B et al.: Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in fibromyalgia patients. Clin. Rheumatol. 23(4), 338-344 (2004).